Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Publication ,  Journal Article
Scialla, JJ; Wolf, M
Published in: Nat Rev Nephrol
May 2014

Disturbances in phosphate homeostasis are common in patients with chronic kidney disease. As kidney function declines, circulating concentrations of phosphate and the phosphate-regulatory hormone, fibroblast growth factor (FGF)-23, rise progressively. Higher serum levels of phosphate and FGF-23 are associated with an increased risk of adverse outcomes, including all-cause mortality and cardiovascular events. The associations between higher FGF-23 levels and adverse cardiovascular outcomes are generally independent of serum phosphate levels, and might be strongest for congestive heart failure. Higher serum phosphate levels are also modestly associated with an increased risk of cardiovascular events even after accounting for FGF-23 levels. This observation suggests that FGF-23 and phosphate might promote distinct mechanisms of cardiovascular toxicity. Indeed, animal models implicate high serum phosphate as a mechanism of vascular calcification and endothelial dysfunction, whereas high levels of FGF-23 are implicated in left ventricular hypertrophy. These seemingly distinct, but perhaps additive, adverse effects of phosphate on the vasculature and FGF-23 on the heart suggest that future population-level and individual-level interventions will need to simultaneously target these molecules to reduce the risk of associated cardiovascular events.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Rev Nephrol

DOI

EISSN

1759-507X

Publication Date

May 2014

Volume

10

Issue

5

Start / End Page

268 / 278

Location

England

Related Subject Headings

  • Vascular Calcification
  • Urology & Nephrology
  • Phosphates
  • Klotho Proteins
  • Humans
  • Glucuronidase
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Endothelial Cells
  • Dietary Proteins
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Scialla, J. J., & Wolf, M. (2014). Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol, 10(5), 268–278. https://doi.org/10.1038/nrneph.2014.49
Scialla, Julia J., and Myles Wolf. “Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.Nat Rev Nephrol 10, no. 5 (May 2014): 268–78. https://doi.org/10.1038/nrneph.2014.49.
Scialla JJ, Wolf M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol. 2014 May;10(5):268–78.
Scialla, Julia J., and Myles Wolf. “Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.Nat Rev Nephrol, vol. 10, no. 5, May 2014, pp. 268–78. Pubmed, doi:10.1038/nrneph.2014.49.
Scialla JJ, Wolf M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol. 2014 May;10(5):268–278.

Published In

Nat Rev Nephrol

DOI

EISSN

1759-507X

Publication Date

May 2014

Volume

10

Issue

5

Start / End Page

268 / 278

Location

England

Related Subject Headings

  • Vascular Calcification
  • Urology & Nephrology
  • Phosphates
  • Klotho Proteins
  • Humans
  • Glucuronidase
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Endothelial Cells
  • Dietary Proteins